Thomas William LeBlanc, MD

Associate Professor of Medicine
Member of the Duke Cancer Institute
Campus mail 2424 Erwin Road, Suite 602, Durham, NC 27705
Phone (919) 668-6551
Email address thomas.leblanc@duke.edu

Dr. LeBlanc is a medical oncologist, palliative care physician, and patient experience researcher.  His clinical practice focuses on the care of patients with hematologic malignancies, with a particular emphasis on myeloid conditions and acute leukemias including acute myeloid leukemia (AML), acute lymphocytic leukemia (ALL), myelodysplastic syndromes (MDS), and myeloproliferative neoplasms (MPNs / MPDs, CML), as well as some lymphomas and multiple myeloma.  He is an active member of the inpatient non-transplant hematologic malignancies care team, based on the 9100 ward of Duke Hospital.

His research interests converge on common issues faced by patients with cancer, particularly those with high-risk or relapsed/refractory hematologic malignancies. Issues of symptom burden and quality of life are of central importance in these settings, and may lead patients to face difficult decision-making scenarios. Dr. LeBlanc’s research explores the experience of patients and families in these settings, and aims to improve patients experiences living with blood cancers, including the involvement of specialist palliative care services to provide an extra layer of support along with their comprehensive cancer care.  

Dr. LeBlanc is the recipient of a Junior Career Development Award grant from the National Palliative Care Research Center (NPCRC), a Sojourns Scholars Leadership Award from the Cambia Health Foundation, and a Mentored Research Scholar Grant from the American Cancer Society. These grants have funded efforts to better understand the experience of patients living with AML, including studies of symptom burden, quality of life, distress, understanding of prognosis, and treatment decision-making. This work has been mentored by a team of expert researchers, including Drs. Amy Abernethy, James Tulsky, Karen Steinhauser, Kath Pollak, and Peter Ubel.  Dr. LeBlanc's work in palliative care research led to his recognition as an "Inspirational Leader under 40" by the American Academy of Hospice and Palliative Medicine (AAHPM), and was granted "fellow" status from the Academy in 2016. Dr. LeBlanc is the 2017-18 Chair of the ASCO Ethics Committee, and Chairs the Scientific Review Committee of the NIH/NINR-funded Palliative Care Research Cooperative Group (PCRC; www.palliativecareresearch.org). He represents the Duke Cancer Institute, a National Comprehensive Cancer Network (NCCN) member, on the NCCN Panel for Acute Myeloid Leukemia.

He completed residency training in Internal Medicine at Duke, as well as fellowships in Medical Oncology and Hospice and Palliative Medicine.  He graduated from the Duke University School of Medicine, also earning a Master of Arts degree in Philosophy during that time, and served as Chief Medical Resident at the Durham VA Medical Center.  He holds board certifications in Internal Medicine, Medical Oncology, and in Hospice and Palliative Medicine.  He is actively involved with teaching of medical students and housestaff at Duke, particularly with regards to issues of patient-doctor communication, and is mentoring several Duke trainees on research projects.

Education and Training

  • Fellow, Medical Oncology, Duke University School of Medicine, 2012 - 2013
  • Fellowship, Hospice And Palliative Medicine, Duke University School of Medicine, 2011 - 2012
  • Chief Medical Resident, Duke University School of Medicine, 2010 - 2011
  • Resident, Duke University School of Medicine, 2007 - 2009
  • Intern, Duke University School of Medicine, 2006 - 2007
  • M.D., Duke University, 2006

Publications

Ray, EM, Riedel, RF, LeBlanc, TW, Rushing, CN, and Galanos, AN. "Assessing the Impact of a Novel Integrated Palliative Care and Medical Oncology Inpatient Service on Health Care Utilization before Hospice Enrollment." Journal of Palliative Medicine 22, no. 4 (April 2019): 420-423.

PMID
30394821
Full Text

LeBlanc, TW, and Erba, HP. "Shifting paradigms in the treatment of older adults with AML." Seminars in Hematology 56, no. 2 (April 2019): 110-117. (Review)

PMID
30926086
Full Text

Aapro, M, Zhang, L, Yennu, S, LeBlanc, TW, and Schwartzberg, L. "Preventing chemotherapy-induced nausea and vomiting with netupitant/palonosetron, the first fixed combination antiemetic: current and future perspective." Future Oncology (London, England) (March 12, 2019).

PMID
30860400
Full Text

Porter, LS, Samsa, G, Steel, JL, Hanson, LC, LeBlanc, TW, Bull, J, Fischer, S, and Keefe, FJ. "Caregiver-guided pain coping skills training for patients with advanced cancer: Background, design, and challenges for the CaringPals study." Clinical Trials (London, England) (February 19, 2019): 1740774519829695-null.

PMID
30782014
Full Text

Vallely, JJ, Hudson, KE, Locke, SC, Wolf, SP, Samsa, GP, Abernethy, AP, and LeBlanc, TW. "Pruritus in patients with solid tumors: an overlooked supportive care need." Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer (February 14, 2019).

PMID
30762144
Full Text

Derry, HM, Maciejewski, PK, Epstein, AS, Shah, MA, LeBlanc, TW, Reyna, V, and Prigerson, HG. "Associations between Anxiety, Poor Prognosis, and Accurate Understanding of Scan Results among Advanced Cancer Patients." Journal of Palliative Medicine (February 6, 2019).

PMID
30724692
Full Text

El-Jawahri, A, Nelson-Lowe, M, VanDusen, H, Traeger, L, Abel, GA, Greer, JA, Fathi, A, Steensma, DP, LeBlanc, TW, Li, Z, DeAngelo, D, Wadleigh, M, Hobbs, G, Foster, J, Brunner, A, Amrein, P, Stone, RM, and Temel, JS. "Patient-Clinician Discordance in Perceptions of Treatment Risks and Benefits in Older Patients with Acute Myeloid Leukemia." The Oncologist 24, no. 2 (February 2019): 247-254.

PMID
30139841
Full Text

Fulton, JJ, LeBlanc, TW, Cutson, TM, Porter Starr, KN, Kamal, A, Ramos, K, Freiermuth, CE, McDuffie, JR, Kosinski, A, Adam, S, Nagi, A, and Williams, JW. "Integrated outpatient palliative care for patients with advanced cancer: A systematic review and meta-analysis." Palliative Medicine 33, no. 2 (February 2019): 123-134.

PMID
30488781
Full Text

Chino, F, Kamal, AH, Chino, J, and LeBlanc, TW. "Disparities in place of death for patients with hematological malignancies, 1999 to 2015." Blood Advances 3, no. 3 (February 2019): 333-338.

PMID
30709864
Full Text

LeBlanc, T, El-Jawahri, A, Roeland, E, and Webb, J. "What’s the Deal with Blood Cancers? Navigating a New Frontier in Palliative Cancer Care (TH313).": Elsevier BV, February 2019.

Full Text

Pages